• About Us
  • Contact Us
askRPA
  • Home
  • News
    Cloud & AI Adoption’s Impact on Indian Small Enterprises

    Cloud & AI Adoption’s Impact on Indian Small Enterprises

    Meta AI: Communication and Creativity Across Apps and Devices

    Meta AI: Communication and Creativity Across Apps and Devices

    Voice & Image Capabilities: ChatGPT’s Exciting New Capabilities

    Voice & Image Capabilities: ChatGPT’s Exciting New Capabilities

    Anthropic, Claude Chatbot’s Makers, Secure Multibillion-Dollar Investment from Amazon

    Anthropic, Claude Chatbot’s Makers, Secure Multibillion-Dollar Investment from Amazon

    DALL·E 3 by OpenAI: The Creative Text-to-Image AI

    DALL·E 3 by OpenAI: The Creative Text-to-Image AI

  • Case Studies
    Santander Consumer Bank Leverages Robotic Process Automation (RPA) to Save $2M on Systems Migration

    Santander Consumer Bank Leverages Robotic Process Automation (RPA) to Save $2M on Systems Migration

    Robotic Process Automation (RPA) Empowers R1 RCM to Successfully Automate More Than 15M Tasks

    Robotic Process Automation (RPA) Empowers R1 RCM to Successfully Automate More Than 15M Tasks

    Dai-ichi Life Insurance Reports that They Saved Over 132000 Hours with Robotic Process Automation (RPA)

  • Blogs
    Explainable AI: A Welcome Clarity Amidst AI Complexity

    Explainable AI: A Welcome Clarity Amidst AI Complexity

    The right automation software can revolutionize how a business operates, but selecting the best solution can be daunting.

    A Guide to Choosing the Best Automation Software for Your Business

    Cobots: Unleashing Manufacturing Excellence with Collaborative Robotics

    Cobots: Unleashing Manufacturing Excellence with Collaborative Robotics

    Collaborative Intelligent Automation (IA): Harnessing AI and Robotics Together

    Collaborative Intelligent Automation (IA): Harnessing AI and Robotics Together

    Generative AI: Exploring Google Bard and ChatGPT

    Generative AI: Exploring Google Bard and ChatGPT

  • IA Congress – November 2023 Chennai, India
  • Events
    • Intelligent Automation Congress – November 2023 Chennai, India
    • 6th International Intelligent Automation Congress
No Result
View All Result
askRPA
  • Home
  • News
    Cloud & AI Adoption’s Impact on Indian Small Enterprises

    Cloud & AI Adoption’s Impact on Indian Small Enterprises

    Meta AI: Communication and Creativity Across Apps and Devices

    Meta AI: Communication and Creativity Across Apps and Devices

    Voice & Image Capabilities: ChatGPT’s Exciting New Capabilities

    Voice & Image Capabilities: ChatGPT’s Exciting New Capabilities

    Anthropic, Claude Chatbot’s Makers, Secure Multibillion-Dollar Investment from Amazon

    Anthropic, Claude Chatbot’s Makers, Secure Multibillion-Dollar Investment from Amazon

    DALL·E 3 by OpenAI: The Creative Text-to-Image AI

    DALL·E 3 by OpenAI: The Creative Text-to-Image AI

  • Case Studies
    Santander Consumer Bank Leverages Robotic Process Automation (RPA) to Save $2M on Systems Migration

    Santander Consumer Bank Leverages Robotic Process Automation (RPA) to Save $2M on Systems Migration

    Robotic Process Automation (RPA) Empowers R1 RCM to Successfully Automate More Than 15M Tasks

    Robotic Process Automation (RPA) Empowers R1 RCM to Successfully Automate More Than 15M Tasks

    Dai-ichi Life Insurance Reports that They Saved Over 132000 Hours with Robotic Process Automation (RPA)

  • Blogs
    Explainable AI: A Welcome Clarity Amidst AI Complexity

    Explainable AI: A Welcome Clarity Amidst AI Complexity

    The right automation software can revolutionize how a business operates, but selecting the best solution can be daunting.

    A Guide to Choosing the Best Automation Software for Your Business

    Cobots: Unleashing Manufacturing Excellence with Collaborative Robotics

    Cobots: Unleashing Manufacturing Excellence with Collaborative Robotics

    Collaborative Intelligent Automation (IA): Harnessing AI and Robotics Together

    Collaborative Intelligent Automation (IA): Harnessing AI and Robotics Together

    Generative AI: Exploring Google Bard and ChatGPT

    Generative AI: Exploring Google Bard and ChatGPT

  • IA Congress – November 2023 Chennai, India
  • Events
    • Intelligent Automation Congress – November 2023 Chennai, India
    • 6th International Intelligent Automation Congress
No Result
View All Result
askRPA
No Result
View All Result

Revolutionizing Drug Development: How AI is Changing the Game

February 22, 2023
Home Uncategorized
Share on LinkedInShare on FacebookShare on WhatsApp

MIT Technology Review recently published an informative article highlighting the impact of AI on drug development and how it is changing the pharmaceutical industry by speeding up the process of clinical trials.

What does AI in drug development mean to patients receiving treatment – A Success Story

“Patients can have this terrible experience of going in and out of hospital, sometimes for years, getting drugs that don’t work.”

Richard Law, Chief Business Officer of Exscientia

Doctors at the Medical University of Vienna enrolled an 82-year-old man with aggressive blood cancer in a trial. The trial used an AI-powered drug matchmaking technology developed by a UK-based company, Exscientia.

The technology paired the patient with the necessary drugs, considering biological differences between individuals. Using Robotic Automation and Machine Learning models, researchers tested over 100 medications on small tissue samples from the patient. The process allowed an exhaustive search for the right drug. The team found an effective drug for the patient without subjecting him to multiple courses of chemotherapy. He is now in complete remission!

What exactly is AI doing in clinical trials?

Developing new drugs from scratch involves several steps –

  • Identifying a target in the body
  • Designing a molecule that will interact with that target
  • Testing the molecule in a lab, and
  • Testing it in humans for safety and efficacy.

Traditionally, chemists have used trial and error, screening candidate drugs by putting target samples into compartments. They then add different molecules to observe reactions. However, this process is time-consuming and often fails, with the high cost of developing a successful drug.

A new generation of AI companies is using Machine Learning to address the failure points in the drug development pipeline. They focus on selecting the right target in the body and designing a suitable molecule to interact with. The process helps them identify the patients the molecule is most likely to help.

Machine Learning can automatically build complex models by harnessing vast amounts of data, including drug and molecular data. The models can predict how drugs might behave in the body, allowing many experiments in silico. ML models can sift through vast pools of potential drug molecules to determine the ones with the best chances of success.

Many companies, including larger pharmaceutical players, are now using Natural Language Processing to mine data from scientific reports. These reports go back decades and include gene sequences and academic papers. Encoded in knowledge graphs, this data captures causal relationships. Machine Learning models can then predict the most promising targets for treating a particular disease.

AI can help speed up clinical trials

Exscientia, a UK-based company, uses Machine Learning to revolutionize the drug development pipeline. In addition to matching patients with existing drugs, the company is also designing new ones with the help of AI. Two drugs developed by Exscientia using this approach have already entered clinical trials, and two more are on the way.

The goal is to make drug discovery faster and cheaper by using Machine Learning. ML can predict how potential drugs might behave in the body and eliminate dead-end compounds before testing. This approach attracts significant investments, with hundreds of startups exploring the use of AI in the pharmaceutical industry.

According to Adityo Prakash, CEO of California-based drug company Verseon, there is a need for new drugs to treat diseases that currently have limited treatment options and often come with long lists of side effects. To facilitate this, new labs are being built around the world, with around two dozen drugs developed with the assistance of AI now in or entering clinical trials.

Who is trying to do what with AI in pharma?

Generate Biomedicines, a startup founded by Flagship Pioneering in Cambridge, Massachusetts, uses generative AI to manipulate random strands of amino acids into protein structures with specific properties.

Absci, another startup, is also using Machine Learning to redesign existing antibodies to make them more effective at binding to foreign matter.

Apriori Bio, also a Flagship Pioneering startup, aims to develop vaccines that can protect against a wide range of viral variants using Machine Learning to predict how well covid-fighting antibodies will work against billions of potential variants.

Verseon uses AI to survey this vast ocean of possibilities and has produced 16 candidate drugs, one already in clinical trials, for various diseases. The company simulates physics problems on the interaction between drugs and proteins in the body, using AI to model molecular interactions.

Next Post
SAP Build Hackathon 2023: Explore Low-Code/No-Code Development with SAP’s Comprehensive Platform

SAP Build Hackathon 2023: Explore Low-Code/No-Code Development with SAP's Comprehensive Platform

    Interested in learning what Automation Solutions can do for your organization?

    We're here to help.

    Subscribe.

    Join askRPA’s weekly Automation Newsletter direct to your Inbox, Sign up now.

    Recommended.

    Bengaluru Airport Implements AI-Powered Vision System for Smoother Operations

    Bengaluru Airport Implements AI-Powered Vision System for Smoother Operations

    August 31, 2023
    UiPath and Peraton Announce Strategic Partnership

    UiPath and Peraton Announce Strategic Partnership

    May 22, 2023
    askRPA

    askRPA is the portal to connect with RPA Geeks and for Latest Automation News, Event and Case Studies etc.

    Follow Us

    Usefull Links

    • About Us
    • Terms and conditions
    • Privacy Policy
    • Contact us

    Tags

    AI Artificial Intelligence askRPA Autoamtion News AutomatePro Automation Automation Anywhere automation news Automation Report Automation Technologies Automation Trends Celonis ChatGPT Cloud Computing CMO data Digital Transformation Entertainment Forrester Gartner Gartner Predictions Gartner Report IA IDP Intelligent Automation Intelligent Automation Congress IoT Low-code development Low-code technologies Low Code Marketing Microsoft Natural Language Processing NLP OpenBots Orica Process Mining Robotic Process Automation Roboyo RPA Salesforce Technology News Turing Bots TuringBots UiPath

    Recent News

    Cloud & AI Adoption’s Impact on Indian Small Enterprises

    Cloud & AI Adoption’s Impact on Indian Small Enterprises

    September 29, 2023

    © 2022 askRPA - Connect Discover Automate

    • Home
    • News
    • Case Studies
    • Blogs
    • IA Congress – November 2023 Chennai, India
    • Events
      • Intelligent Automation Congress – November 2023 Chennai, India
      • 6th International Intelligent Automation Congress

    © 2022 askRPA - Connect Discover Automate